Gary H. Loeb
2019
Compensation breakdown
| Non-Equity Incentive Plan | $87,200 |
|---|---|
| Option Awards | $1,788,475 |
| Salary | $166,667 |
| Other | $683 |
| Total | $2,043,025 |
Loeb received $1.8M in option awards, accounting for 88% of the total pay in 2019.
Loeb also received $87.2K in non-equity incentive plan, $166.7K in salary and $683 in other compensation.
Rankings
In 2019, Gary H. Loeb's compensation ranked 5,821st out of 13,971 executives tracked by ExecPay. In other words, Loeb earned more than 58.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,821 out of 13,971 | 58th |
Division Manufacturing | 2,181 out of 5,701 | 62nd |
Major group Chemicals And Allied Products | 785 out of 2,200 | 64th |
Industry group Drugs | 661 out of 1,886 | 65th |
Industry Biological Products, Except Diagnostic Substances | 157 out of 389 | 60th |
Pay ratio
| Gary H. Loeb's Pay | $2,043,025 |
|---|---|
| Median Employee's Pay | $159,900 |
| Pay Ratio | 13to 1 |
In 2019, the annual total compensation of Gary H. Loeb was $2,043,025.
The annual total compensation of the median employee at Sangamo Biosciences was $159,900.
The ratio of Gary H. Loeb's pay to the pay of median employee was therefore 13 to one.
Loeb's colleagues
We found six more compensation records of executives who worked with Gary H. Loeb at Sangamo Biosciences in 2019.
2019
Alexander Macrae
Sangamo Biosciences
Chief Executive Officer
2019
Sung Lee
Sangamo Biosciences
Chief Financial Officer
2019
Adrian Woolfson
Sangamo Biosciences
Executive Vice President, Research and Development
2019
Stéphane Boissel
Sangamo Biosciences
Chief Financial Officer
2019
R Ramelmeier
Sangamo Biosciences
Executive Vice President, Technical Operations
2019
Kathy Yi
Sangamo Biosciences